PRLD Research and Charts

PRLD - Prelude Therapeutics Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-09 (Delayed quote data 2025-01-06)

Last 1.33	Change ⇓ -0.06 (-4.32%)	Volume 270,812
	Open 1.38	High 1.43	Low 1.29

8EMA (Daily) 1.28	40EMA (Daily) 1.26	50EMA (Daily) 1.37	STO (Daily) 62.278	MACD Hist (Daily) 0.093
8EMA (Weekly) 1.308	40EMA (Weekly) 2.71	50EMA (Weekly) 2.99	STO (Weekly) 27.996	MACD Hist (Weekly) 0.085


Company Profile
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.